Tian-yi Yuan

Beijing Key Laboratory Of Innovative Drug Discovery And Polymorphic Research For Cerebrovascular Diseases, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Metabolic reprogramming in pulmonary arterial hypertension.

Metabolic reprogramming in pulmonary arterial hypertension.

Journal: Pharmacology & therapeutics

Published: December 31, 2025

Corrigendum to "Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy" [Biomed. Pharmacother. (2023) 160 114382].

Corrigendum to "Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy" [Biomed. Pharmacother. (2023) 160 114382].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 11, 2024

Baicalein attenuates rotenone-induced SH-SY5Y cell apoptosis through binding to SUR1 and activating ATP-sensitive potassium channels.

Baicalein attenuates rotenone-induced SH-SY5Y cell apoptosis through binding to SUR1 and activating ATP-sensitive potassium channels.

Journal: Acta pharmacologica Sinica

Published: May 04, 2023

Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy.

Salvianolic acid A improve mitochondrial respiration and cardiac function via inhibiting apoptosis pathway through CRYAB in diabetic cardiomyopathy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 04, 2023

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.

Journal: Pharmacological research

Published: April 06, 2022

Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension via STAT3/HIF-1α/VEGF and FAK/AKT Signaling Pathways.

Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension via STAT3/HIF-1α/VEGF and FAK/AKT Signaling Pathways.

Journal: Frontiers in pharmacology

Published: January 27, 2022

Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.

Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.

Journal: Acta pharmacologica Sinica

Published: September 06, 2021

Cardioprotective Effects of Puerarin-V on Isoproterenol-Induced Myocardial Infarction Mice Is Associated with Regulation of PPAR-Υ/NF-κB Pathway.

Cardioprotective Effects of Puerarin-V on Isoproterenol-Induced Myocardial Infarction Mice Is Associated with Regulation of PPAR-Υ/NF-κB Pathway.

Journal: Molecules (Basel, Switzerland)

Published: November 12, 2018

A novel hypertensive crisis rat model established by excessive norepinephrine infusion and the potential therapeutic effects of Rho-kinase inhibitors on it.

A novel hypertensive crisis rat model established by excessive norepinephrine infusion and the potential therapeutic effects of Rho-kinase inhibitors on it.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 14, 2018

Vasorelaxant effect of quercetin on cerebral basilar artery in vitro and the underlying mechanisms study.

Vasorelaxant effect of quercetin on cerebral basilar artery in vitro and the underlying mechanisms study.

Journal: Journal of Asian natural products research

Published: April 26, 2018

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents.

Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents.

Journal: Molecules (Basel, Switzerland)

Published: September 19, 2017

The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.

The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.

Journal: Journal of ethnopharmacology

Published: September 23, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026